The recent epidemic in Wuhan has touched the hearts of people all over the country, so in addition to masks, chemical resistant clothing and other clothing, what else is urgently needed by the crowd? In fact, the reason is very simple, that is nucleic acid testing reagents. Suspected cases need to have its help in order to become confirmed cases, thus providing help to doctors.
What are the Nucleic Acid Testing Stocks?
Currently, nucleic acid testing stocks in the A-share market include Kewa Bio, Daan Genetics, Dean Diagnostics, Shuoshi Bio, Turbine Life, and Anke Bio. These stocks have been in the industry for a long time, so in the current crisis, these companies can take the lead in the development of relevant testing reagents to help doctors identify the virus. So we can't rule out the possibility that these companies' products will be the first to be used and the first to clean up their stockpiles.
1Kehua Bio: the company's main in vitro clinical immunodiagnostic reagents, in vitro clinical chemical diagnostic reagents, nucleic acid diagnostic reagents, genetic engineering drugs and in vitro diagnostic reagents with automated diagnostic testing instruments, such as research, production and sales.
2Daan Gene: On January 28, the new coronavirus 2019-nCoV nucleic acid detection kit declared by Daan Gene in emergency was approved and passed by the State Drug Administration, which issued a medical device registration certificate (Registration Certificate No.: GuoMeZhiQi20203400063).
3Dian Diagnostics: the leading testing instrument field, the domestic independent medical service diagnostic giant.
4 Shuo Shi Bio: December 31, 2019 the company said on the interactive platform: the company currently has influenza A / B influenza virus antigen detection kit (colloidal gold method) and other influenza detection products for influenza virus detection.
5Turbine Life: the earliest IVD detection based on flow fluorescence technology into the enterprise, and overseas companies Luminex years of in-depth cooperation, based on the xMAP technology development of high-throughput flow fluorescence platform with high speed, low-cost advantages.
6Anchor Bio: the company is one of the important manufacturers of interferon; the company's wholly owned subsidiary, Soho Yiming is the most peptide raw material approvals in China, the company also has thymus pentapeptide, thymus Faxin raw material drug approvals, which is also an important drug to strengthen immunity to the preparation of the two drugs.
In summary, this is the domestic currently listed companies related to nucleic acid testing.